Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. J. Gómez-Román, S. G. Iosu, B. Angulo, N. M. Montserrat, L. F. Servando (Santander, Pamplona, Madrid, Spain). Organization and results of the EGFR mutation Spanish quality control program. Eur Respir J 2012; 40: Suppl. 56, 3138

Member's Comments

No comment yet.

Related content which might interest you: Rasch modelling for validation of Hindi version of abbreviated World Health Organization quality of life scale (WHOQOL-Bref) for assessment of health related quality of life in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008 Rasch analysis for evaluating abbreviated World Health Organization quality of life questionnaire (WHOQOL-Bref) in north Indian patients with bronchial asthma Source: Annual Congress 2011 - Asthma: a heterogeneous disease Year: 2011 The effect of changes in quality of life in patients with lung cancer in the observation period (European Organization for Research and treatment of Cancer) EORTC QLQ-C 30 results of the evaluation and follow-up (AKAYAK-1 project) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Health status (quality of life) of patients with COPD is improved by a specific educational program, Edu-Care Source: Annual Congress 2004 - Outcome of pulmonary rehabilitation Year: 2004 The World Health Organization global aDSM database: generating evidence on the safety of new treatment regimens for drug-resistant tuberculosis Source: Eur Respir J, 51 (3) 1701643; 10.1183/13993003.01643-2017 Year: 2018 Resources and support of the World Health Organization to improve air quality Source: International Congress 2019 – Is your patient dying from air pollution? Year: 2019 Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014 Health status measurements in alpha-1antitrypsin deficiency (AATD) Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Update on asthma control in five European countries: results of a 2008 survey Source: Eur Respir Rev 2009; 19: 150-157 Year: 2010 External quality assessment (EQA) for laboratory diagnosis of alpha1-antitrypsin deficiency (AATD) – Program driven by the European Alpha-1-Research Collaboration (EARCO) network Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021 Assessment of asthma control based on French guidelines criteria. Results from a pharmacy-based study Source: Eur Respir J 2006; 28: Suppl. 50, 684s Year: 2006 Validation of asthma quality of life questionnaire: Brazilian version Source: Eur Respir J 2006; 28: Suppl. 50, 843s Year: 2006 World Health Organization treatment outcome definitions for tuberculosis: 2021 update Source: Eur Respir J, 58 (2) 2100804; 10.1183/13993003.00804-2021 Year: 2021 The assessment of the effect of changes in lung cancer follow-up period to the quality of life by using EQ-5D questionnaire and follow data (the project of AKAYAK-1) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Comparison of quality of life scores with modified Medical Research Council (mMRC) dyspnoea scale using data from the European health-related quality of life study Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Assessment of responsiveness to the German translation of the ²marks‘ asthma quality of life questionnaire² Source: Annual Congress 2004 - Asthma and perceived health status Year: 2004 European mapping of EGFR mutation test and EGFR tyrosine kinase inhibitors availability in thoracic oncology Source: International Congress 2015 – Quality management in lung cancer Year: 2015 The new World Health Organization classification of lung tumours Source: Eur Respir J 2001; 18: 1059-1068 Year: 2001 Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country Source: Eur Respir J 2017; 49(1): 1601967; DOI: 10.1183/13993003.01967-2016 Year: 2017 FACT-L (functional assessment of cancer therapy-lung) psychometric properties of the Turkish version of quality of life scale (validity and reliability) and determination using the clinic (Akkaya-1 project) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013